KRQE Blogs

Endovascular Engineering's Hēlo™ Thrombectomy System Receives IDE Approval to Start ENGULF Pivotal Trial for the Treatment of Pulmonary Embolism

MENLO PARK, Calif., Jan. 11, 2024 /PRNewswire/ -- Endovascular Engineering ("E2"), a medical device company focused on the development and deployment of groundbreaking clot removal technologies that ...
Yahoo Finance

E2 (Endovascular Engineering, Inc.) Announces Completion of Enrollment in the ENGULF Pivotal Cohort for Treatment of Pulmonary Embolism

Pivotal trial evaluates safety and efficacy of the Hēlo™ PE Thrombectomy System for the removal of blood clots from the lungs MENLO PARK, Calif., June 23, 2025 /PRNewswire/ -- E2 (Endovascular ...
Yahoo Finance

E2 (Endovascular Engineering, Inc) Presents ENGULF Pivotal Study as a Late-Breaking Clinical Trial at the VIVA Conference

"On behalf of the ENGULF Investigators, I am proud to share the positive results of the ENGULF study of the Hēlo Thrombectomy System," said Dr. Andrew Klein. "E2 took a unique approach, by innovating ...
MarketWatch

Endovascular Engineering Announces Dual Late-Breaking Presentations at SIR and SCAI 2026 Highlighting Validation of Blood Return and Comprehensive ENGULF Study Results

The MarketWatch News Department was not involved in the creation of this content. MENLO PARK, Calif., March 19, 2026 /PRNewswire/ -- Endovascular Engineering, Inc. ("E2") today announced that two ...
FOX40 News

Endovascular Engineering Announces First Patient Enrolled in ENGULF Pivotal Trial with its Hēlo™ PE Thrombectomy System for the Treatment of Pulmonary Embolism

MENLO PARK, Calif., Feb. 20, 2024 /PRNewswire/ -- Endovascular Engineering, Inc. ("E2"), a pioneering medical device company at the forefront of advancing clot removal technologies for venous ...
MarketWatch

E2 (Endovascular Engineering) Raises $80 Million Series C to Advance Next-Generation Thrombectomy Platform as Pulmonary Embolism Treatment Evolves

The MarketWatch News Department was not involved in the creation of this content. Gilde Healthcare and Norwest co-led round to commercialize the Hēlo(R) Thrombectomy Platform MENLO PARK, Calif., April ...